The Innovation Space — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Ajaya Bio develops bispecific therapies designed to eliminate disease-driving cells while sparing healthy ones, using its BOLT-360 discovery platform built around hybrid binders, precise activation, and advanced linkers.
BiotechDeep TechPhiladelphia, US
Mohit S.(Founder)inMohit Sachdeva(Executive Officer, Director)in
Co-investorsBen Franklin Technology Partners
Aloe Therapeutics develops AIM-001, a localized cell-based immunotherapy implanted at a tumor site during biopsy or resection surgery to activate the immune system and make patients more responsive to checkpoint immunotherapy.
BiotechHealthtechDarnestown, US
Martha Sklavos(Executive Officer, Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.